Fonte: Supportive Care in Cancer. Unidade: FO
Assuntos: CÉLULAS QUE APRESENTAM ANTÍGENOS, HEMATOMA, MANIFESTAÇÕES NEUROMUSCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
EDUARDO, Fernanda P et al. Retrospective study of the digestive tract mucositis derived from myeloablative and non-myeloablative: reduced-intensity conditionings with busulfan in hematopoietic cell transplantation patient. Supportive Care in Cancer, 2018Tradução . . Disponível em: https://doi.org/10.1007/s00520-018-4362-3. Acesso em: 15 nov. 2025.APA
Eduardo, F. P., Bezinelli, L. M., Gobbi, M., Rosin, F. C. P., Carvalho, D. L. C., Ferreira, M. H., et al. (2018). Retrospective study of the digestive tract mucositis derived from myeloablative and non-myeloablative: reduced-intensity conditionings with busulfan in hematopoietic cell transplantation patient. Supportive Care in Cancer. doi:10.1007/s00520-018-4362-3NLM
Eduardo FP, Bezinelli LM, Gobbi M, Rosin FCP, Carvalho DLC, Ferreira MH, Silva CC da, Hamerschlak N, Corrêa L. Retrospective study of the digestive tract mucositis derived from myeloablative and non-myeloablative: reduced-intensity conditionings with busulfan in hematopoietic cell transplantation patient [Internet]. Supportive Care in Cancer. 2018 ;[citado 2025 nov. 15 ] Available from: https://doi.org/10.1007/s00520-018-4362-3Vancouver
Eduardo FP, Bezinelli LM, Gobbi M, Rosin FCP, Carvalho DLC, Ferreira MH, Silva CC da, Hamerschlak N, Corrêa L. Retrospective study of the digestive tract mucositis derived from myeloablative and non-myeloablative: reduced-intensity conditionings with busulfan in hematopoietic cell transplantation patient [Internet]. Supportive Care in Cancer. 2018 ;[citado 2025 nov. 15 ] Available from: https://doi.org/10.1007/s00520-018-4362-3
